Display options
Share it on

Paediatr Drugs. 2008;10(3):177-92. doi: 10.2165/00148581-200810030-00006.

Epidemiology and management options for colorectal cancer in children.

Paediatric drugs

Raya Saab, Wayne L Furman

Affiliations

  1. Pediatric Hematology-Oncology, American University of Beirut, Beirut, Lebanon.

PMID: 18454570 DOI: 10.2165/00148581-200810030-00006

Abstract

Colorectal carcinoma (CRC), although primarily a disease of adulthood, accounts for 2% of malignancies in adolescents and has been reported in children as young as 9 months of age. Our knowledge of CRC in pediatrics is based on a handful of case series and case reports. Apart from one small clinical trial, there has been a lack of prospective clinical studies in this age group. Based on these published reports, most CRC in children is sporadic, but it can also arise in the setting of predisposing conditions, such as gastrointestinal polyposis syndromes, nonpolyposis familial cancer syndromes, and inflammatory bowel disease. Despite some similarities to adult disease, CRC in childhood may be intrinsically different biologically, because it differs from adult-onset CRC in several respects. Childhood CRC tends to be diagnosed at an advanced stage, is largely of mucinous histology, and (probably because of these features) tends to have a poorer outcome. As a result of its rarity in children and the lack of prospective pediatric studies, recommendations for therapy are primarily extrapolated from adult clinical trials. A review of pediatric case series in the English literature emphasizes the prognostic significance of stage of disease, as well as extent of surgical resection. As in adults, early detection is critical in an effort to capture the disease at less advanced stages. Complete surgical resection with aggressive lymph node dissection is essential for cure, and neoadjuvant chemotherapy may be used in an effort to render unresectable lesions resectable. Active agents in adults with CRC include fluorouracil, folinic acid (leucovorin), oxaliplatin, and irinotecan. Furthermore, newer targeted therapeutic agents, such as bevacizumab and cetuximab, have added additional efficacy to the standard chemotherapy backbone. Collaborative multi-institutional pediatric clinical trials are needed to evaluate the prognosis, optimal treatment response, and the basic biology of childhood onset CRC.

References

  1. Surgery. 1983 Mar;93(3):409-14 - PubMed
  2. J Pediatr Hematol Oncol. 2005 Jan;27(1):39-41 - PubMed
  3. Int J Cancer. 1988 Apr 15;41(4):513-7 - PubMed
  4. Eur J Pediatr Surg. 2001 Oct;11(5):338-41 - PubMed
  5. Ann Surg Oncol. 1995 Sep;2(5):386-91 - PubMed
  6. Hepatogastroenterology. 1997 Mar-Apr;44(14):441-4 - PubMed
  7. Cell. 1996 Oct 18;87(2):159-70 - PubMed
  8. Arch Pathol Lab Med. 2000 Dec;124(12):1759-63 - PubMed
  9. Ann Thorac Surg. 2000 Aug;70(2):380-3 - PubMed
  10. Cancer. 2001 Jul 15;92(2):452 - PubMed
  11. J Med Genet. 1996 Feb;33(2):157-60 - PubMed
  12. Histopathology. 1988 Dec;13(6):619-30 - PubMed
  13. CA Cancer J Clin. 2004 Nov-Dec;54(6):295-308 - PubMed
  14. J Clin Oncol. 2005 Jul 10;23(20):4553-60 - PubMed
  15. J Clin Oncol. 2000 Aug;18(16):2938-47 - PubMed
  16. Ann Oncol. 2005 Mar;16(3):425-9 - PubMed
  17. J Clin Oncol. 1997 Jan;15(1):246-50 - PubMed
  18. J Pediatr Gastroenterol Nutr. 1991 Apr;12(3):394-9 - PubMed
  19. Lancet. 2000 Mar 25;355(9209):1041-7 - PubMed
  20. J Clin Oncol. 2004 Jan 1;22(1):23-30 - PubMed
  21. N Engl J Med. 2004 Jun 3;350(23):2335-42 - PubMed
  22. N Engl J Med. 2005 Jun 30;352(26):2696-704 - PubMed
  23. Cancer. 1994 Apr 15;73(8):2076-82 - PubMed
  24. N Engl J Med. 1993 Apr 1;328(13):901-6 - PubMed
  25. Ann Surg. 2004 Oct;240(4):624-8; discussion 628-30 - PubMed
  26. Cancer. 1958 Jul-Aug;11(4):855-7 - PubMed
  27. Dis Colon Rectum. 1975 Jan-Feb;18(1):1-3 - PubMed
  28. J Surg Oncol. 2000 Feb;73(2):70-4 - PubMed
  29. Ann Intern Med. 1998 Jun 1;128(11):900-5 - PubMed
  30. Med Pediatr Oncol. 1999 Nov;33(5):470-5 - PubMed
  31. Clin Colorectal Cancer. 2005 Nov;5(4):257-62 - PubMed
  32. Hematol Oncol Clin North Am. 2005 Jun;19(3):565-71, vii-viii - PubMed
  33. Gastroenterology. 1995 Jun;108(6):1657-65 - PubMed
  34. AJR Am J Roentgenol. 2000 Apr;174(4):1005-8 - PubMed
  35. Gastroenterology. 1985 Aug;89(2):328-36 - PubMed
  36. J Clin Oncol. 2005 May 20;23(15):3502-8 - PubMed
  37. J Pediatr. 1956 Mar;48(3):279-91 - PubMed
  38. J Am Coll Surg. 2001 Jun;192(6):719-25 - PubMed
  39. Br J Cancer. 2002 Aug 12;87(4):393-9 - PubMed
  40. J Clin Oncol. 2005 Dec 20;23(36):9441-2 - PubMed
  41. J Clin Oncol. 2005 Mar 20;23(9):2038-48 - PubMed
  42. Arch Pathol Lab Med. 2003 Jun;127(6):673-9 - PubMed
  43. Ann Surg Oncol. 2003 Jan-Feb;10(1):65-71 - PubMed
  44. J Pediatr Surg. 1992 Aug;27(8):1085-9; discussion 1089-90 - PubMed
  45. Gastroenterology. 2000 Sep;119(3):837-53 - PubMed
  46. Gastroenterology. 2001 Jul;121(1):198-213 - PubMed
  47. J Clin Oncol. 1999 Nov;17(11):3553-9 - PubMed
  48. Dis Colon Rectum. 1977 Nov-Dec;20(8):661-8 - PubMed
  49. Br J Surg. 2004 Mar;91(3):349-54 - PubMed
  50. Pediatr Radiol. 1989;19(8):504-8 - PubMed
  51. J Nucl Med. 2003 Nov;44(11):1797-803 - PubMed
  52. Indian Pediatr. 2000 Dec;37(12):1353-8 - PubMed
  53. J Pediatr. 2001 May;138(5):621-8 - PubMed
  54. J Clin Oncol. 2008 Jan 20;26(3):399-405 - PubMed
  55. Pediatrics. 1963 Oct;32:558-71 - PubMed
  56. Lancet. 1995 Apr 15;345(8955):939-44 - PubMed
  57. Ann Surg. 2004 Jun;239(6):818-25; discussion 825-7 - PubMed
  58. Ann Intern Med. 2003 Apr 1;138(7):560-70 - PubMed
  59. Gastroenterology. 2003 May;124(6):1574-94 - PubMed
  60. South Med J. 1990 Apr;83(4):383-5 - PubMed
  61. Drugs. 2005;65(14):1935-47 - PubMed
  62. Eur J Pediatr Surg. 2003 Feb;13(1):66-8 - PubMed
  63. Cancer. 1985 Mar 15;55(6):1322-6 - PubMed
  64. Pediatr Blood Cancer. 2008 Mar;50(3):588-93 - PubMed
  65. J Pediatr Surg. 1999 Oct;34(10):1499-504 - PubMed
  66. Gut. 2005 Aug;54(8):1146-50 - PubMed
  67. J Clin Oncol. 2004 Jun 1;22(11):2084-91 - PubMed
  68. Gastroenterology. 2000 Dec;119(6):1447-53 - PubMed
  69. Clin Gastroenterol. 1976 Sep;5(3):505-25 - PubMed
  70. Cell. 1990 Jun 1;61(5):759-67 - PubMed
  71. Clin Colorectal Cancer. 2005 Nov;5(4):263-7 - PubMed
  72. J Clin Oncol. 2004 Aug 15;22(16):3408-19 - PubMed
  73. J Clin Oncol. 2005 Dec 1;23(34):8671-8 - PubMed
  74. Dis Colon Rectum. 1998 Oct;41(10):1244-9 - PubMed
  75. N Engl J Med. 2004 Jun 3;350(23):2343-51 - PubMed
  76. J Clin Oncol. 2005 Dec 1;23(34):8706-12 - PubMed
  77. Ann Surg. 1965 Aug;162:279-84 - PubMed
  78. Am Surg. 1995 Jan;61(1):78-82 - PubMed
  79. Gastroenterology. 1997 Oct;113(4):1146-58 - PubMed
  80. Cancer. 2006 Sep 1;107(5 Suppl):1153-61 - PubMed
  81. J Clin Oncol. 2005 Aug 1;23(22):4866-75 - PubMed
  82. Med Pediatr Oncol. 1999 Jun;32(6):459-60 - PubMed
  83. Curr Opin Pediatr. 2002 Oct;14(5):576-82 - PubMed
  84. Annu Rev Med. 2005;56:539-54 - PubMed
  85. Eur J Cancer. 2005 Jan;41(2):272-9 - PubMed
  86. Dig Dis Sci. 1990 Mar;35(3):349-52 - PubMed
  87. Eur J Surg Oncol. 2006 Nov;32(9):941-7 - PubMed
  88. J Pediatr Surg. 1992 Jul;27(7):919-21 - PubMed
  89. CA Cancer J Clin. 1997 Mar-Apr;47(2):93-112 - PubMed
  90. Semin Nucl Med. 2004 Jul;34(3):209-23 - PubMed
  91. J Clin Oncol. 1997 Mar;15(3):938-46 - PubMed
  92. N Engl J Med. 1988 Sep 1;319(9):525-32 - PubMed
  93. Chest. 2001 Apr;119(4):1069-72 - PubMed
  94. Ann Intern Med. 1993 May 15;118(10):785-90 - PubMed
  95. J Clin Oncol. 2005 Jun 1;23(16):3706-12 - PubMed
  96. Semin Oncol. 2005 Feb;32(1):11-23 - PubMed
  97. N Engl J Med. 2000 Sep 28;343(13):905-14 - PubMed
  98. Am J Clin Pathol. 1956 Jul;26(7):778-86 - PubMed
  99. Ann Thorac Surg. 1992 May;53(5):780-5; discussion 785-6 - PubMed
  100. J Gastroenterol Hepatol. 2005 Nov;20(11):1634-40 - PubMed
  101. Semin Oncol. 1991 Aug;18(4):381-7 - PubMed
  102. J Pediatr Surg. 1976 Dec;11(6):967-71 - PubMed
  103. J Clin Oncol. 2004 May 15;22(10):1797-806 - PubMed
  104. Gastroenterol Clin North Am. 2006 Sep;35(3):517-31 - PubMed
  105. Ann Surg Oncol. 2006 Jun;13(6):887-98 - PubMed
  106. Semin Oncol. 2006 Dec;33(6 Suppl 11):S36-8 - PubMed
  107. N Engl J Med. 1995 Mar 30;332(13):839-47 - PubMed
  108. J Clin Oncol. 2003 Jan 1;21(1):60-5 - PubMed
  109. Gastroenterology. 1985 Aug;89(2):398-407 - PubMed
  110. N Engl J Med. 1993 Dec 30;329(27):1977-81 - PubMed
  111. Ann Surg Oncol. 1996 Jul;3(4):344-8 - PubMed
  112. Gastroenterology. 1999 Jun;116(6):1453-6 - PubMed
  113. N Engl J Med. 2004 Jul 22;351(4):337-45 - PubMed
  114. J Clin Oncol. 2007 Dec 20;25(36):5808-14 - PubMed
  115. J Clin Oncol. 2001 Nov 1;19(21):4097-106 - PubMed
  116. Ann Surg. 1986 Feb;203(2):123-8 - PubMed
  117. N Engl J Med. 2000 Jan 13;342(2):137-8 - PubMed
  118. Semin Oncol. 2004 Jun;31(3):374-81 - PubMed
  119. Cancer Res. 1990 Dec 1;50(23):7717-22 - PubMed
  120. N Engl J Med. 1994 Dec 22;331(25):1669-74 - PubMed
  121. Arch Pathol Lab Med. 2000 Jul;124(7):979-94 - PubMed
  122. Cancer. 1976 Apr;37(4):1891-1900 - PubMed
  123. Ann Oncol. 2005 Aug;16(8):1305-10 - PubMed
  124. Eur J Pediatr. 2001 Mar;160(3):168-72 - PubMed
  125. Dis Colon Rectum. 2002 Jul;45(7):887-9 - PubMed
  126. Br J Surg. 1994 Oct;81(10):1485-9 - PubMed
  127. Dis Colon Rectum. 1993 Jan;36(1):49-54 - PubMed
  128. Cancer. 2000 May 15;88(10):2398-424 - PubMed
  129. Ann Oncol. 2004 Jun;15(6):933-9 - PubMed

MeSH terms

Publication Types

Grant support